Loading...
Disclaimer: Informational only — not medical advice. AI hypotheses are not clinically validated. Medic Oath is for informational and educational purposes only — not medical advice. AI-generated hypotheses have not been clinically validated. Always consult a qualified healthcare professional. Privacy · Terms
A rare neurodegenerative disorder of the astrocytes comprised of two clinical forms: Alexander disease (AxD) type I and type II manifesting with various degrees of macrocephaly, spasticity, ataxia and seizures and leading to psychomotor regression and death.
Curcumin and withanoside IV synergistically upregulate HSP70 expression through HSF1 activation, promoting proper GFAP folding and reducing Rosenthal fiber formation. HSP70 acts as a molecular chaperone to prevent GFAP misfolding and facilitates autophagy-mediated clearance of aggregated proteins via LAMP2A pathway.
Berberine activates AMPK through LKB1 phosphorylation, leading to mTOR inhibition and ULK1 activation. This enhances astrocyte-specific autophagy flux, promoting clearance of misfolded GFAP aggregates and Rosenthal fibers. Additionally, berberine modulates TFEB nuclear translocation to upregulate lysosomal biogenesis genes.
Quercetin-3-glucuronide from Houttuynia cordata combined with sub-therapeutic ruxolitinib synergistically inhibits JAK2/STAT3 signaling. This shifts reactive astrocytes from A1 (neurotoxic) to A2 (neuroprotective) phenotype, reducing complement cascade activation (C3, C1q) and promoting neurotrophin expression (BDNF, GDNF).
Baicalein restores proper AQP4 polarization in astrocytic endfeet through modulation of dystrophin-dystroglycan complex and α-syntrophin interactions. Enhanced AQP4 polarization improves glymphatic flow and perivascular clearance of protein aggregates, reducing neuroinflammation via NF-κB pathway inhibition.
Gastrodin and 4-hydroxybenzyl alcohol from Gastrodia elata modulate PERK-eIF2α-ATF4 pathway to reduce protein synthesis load while enhancing CHOP-mediated protein quality control. This integrated stress response reduces ER stress and allows proper GFAP folding, while activating GADD34 for recovery phase regulation.
Gypenosides activate SIRT1-mediated PGC-1α deacetylation, promoting mitochondrial biogenesis through TFAM upregulation. Enhanced mitochondrial function supports ATP-dependent chaperone systems and reduces oxidative stress that exacerbates GFAP aggregation. NRF1 and NRF2 activation further supports antioxidant response.
Designer PROTAC molecules selectively degrade E3 ligases that target p62/SQSTM1 for degradation, leading to p62 accumulation. Stabilized p62 enhances selective autophagy of ubiquitinated GFAP aggregates through its UBA domain and LC3-interacting region, promoting aggregate clearance via NBR1 co-recruitment.